Lorcaserin Hydrochloride - CAS# 846589-98-8 Catalog No.:M10168-2 thereby preventing cross-linking of the

thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains

Formula: C6H5NO2

WIN55212-2

dose-dependently increases the withdrawal latency of the ipsilateral hindpaw at 1-3 and 1-5 h after injection at days 3 and 7 postsurgery (SNL 3D+GSK and SNL 7D+GSK

Chemical Name: methyl 3-[4-(4-carbamimidoylbenzoyl)piperazine-1-carbonyl]-5-[(4-carbamimidoylpiperazin-1-yl)methyl]benzoate trihydrochloride

Lorcaserin Hydrochloride - CAS# 846589-98-8 Catalog No.:M10168-2 thereby preventing cross-linking of theLorcaserin HCl is discontinued (DEA controlled substance). Lorcaserin hydrochloride is a selective 5 HT2C receptor agonist. In vitro testing lorcaserin hydrochloride shows reasonable selectivity for 5 HT2C over other related targets. Lorcaserin has shown 100x selectivity for 5 HT2C versus the closely related 5 HT2B receptor, and 17x selectivity over the 5 HT2A receptor. Product information CAS Number: 846589 98 8 Molecular Weight: 232. 15 Formula: